Smith Thornton Advisors
ABBV icon

Smith Thornton Advisors’s AbbVie ABBV Stock Holding History

Smith Thornton Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$223K Hold
852
– – 0.1% 128
2026
Q2 		$211K Buy
+852
New +$183K 0.09% 131

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Smith Thornton Advisors's ABBV Position: Q3 2026 in Review

Smith Thornton Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 852 shares worth $223K. The position accounts for 0.1% of the portfolio, ranked #128.

Smith Thornton Advisors first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 1,567 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Smith Thornton Advisors held 852 shares of AbbVie worth $223K as of Q3 2026.
  • Smith Thornton Advisors left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.1% of Smith Thornton Advisors's portfolio in Q3 2026, its #128 holding.
  • Smith Thornton Advisors first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 1,567 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Smith Thornton Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.